Dr. Sandeep Arora, Director – Medical Affairs for AstraZeneca Pharma India’s Biopharmaceutical and Rare Disease Business Units, has resigned to pursue career opportunities elsewhere. His last day with the company will be September 15, 2026. AstraZeneca is currently in the process of appointing a suitable replacement for this senior management position.
Senior Management Change at AstraZeneca Pharma India
AstraZeneca Pharma India Limited has announced the resignation of Dr. Sandeep Arora, who held the position of Director – Medical Affairs for both the Biopharmaceutical Business Unit and the Rare Disease Business Unit. Dr. Arora has elected to pursue a career path outside of the organization.
Effective Date and Transition
His tenure with AstraZeneca Pharma India will officially conclude at the close of business hours on September 15, 2026. The company has indicated that Dr. Arora will complete his handover period to ensure a smooth transition. AstraZeneca has extended best wishes to Dr. Arora for his future endeavors.
Replacement Process Underway
The company is actively engaged in the process of identifying and appointing a suitable candidate to fill the senior management role vacated by Dr. Arora. This position is deemed critical in terms of SEBI Listing Regulations.
Source: BSE
